Antibodies Market
Antibodies Market Analysis By Product Type (Monoclonal Antibodies, Polyclonal Antibodies, Immune Checkpoint Antibodies, Epitope Tag Antibodies, Isotype Control Antibodies, Primary Antibodies, Assay Antibodies), By End User & Region - Global Market Insights 2022-2032
Analysis of Antibodies market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Antibodies Market Outlook (2022-2032)
As of 2022, the global antibodies market size is valued at US$ 197.3 billion and is projected to exhibit expansion at a stellar CAGR of 11.9% over the next ten years. The market is anticipated to bloat 3X to surpass a valuation of US$ 608 billion by the end of 2032.
Antibodies have various purposes including diagnostics along with other therapeutic purposes like indication of various diseases like rheumatoid arthritis, non-Hodgkin lymphoma, psoriasis, Cohn's disease, macular degeneration, hypercholesterolemia, and asthma.
Robust investments in healthcare research and development are expected to drive antibodies market growth potential in North America. This regional market is expected to account for nearly 49% of the global market share by 2032-end. Furthermore, effective harmonization of product development, approval, and registration guidelines in some of the major markets, such as the United States and the European Union, are speeding the research and development of antibody-related products.
Speaking of therapeutic antibodies, monoclonal and polyclonal antibodies are also gaining popularity. Antibodies are also the dominant biopharmaceuticals targeting the abnormal cells specifically. Owing to this, various pharmaceutical and biotechnology companies have shifted their focus on significantly developing advanced antibodies in order to treat chronic diseases like cancer, rheumatic heart disease, and arthritis.
A robust increase in healthcare R&D spending is anticipated to incite growth in the research reagents market across the forecast period. Supportive government initiatives to develop healthcare infrastructure, increasing prevalence of chronic diseases, frequent viral outbreaks, and rising demand for protein therapeutics are other factors that are expected to favor antibody discovery market growth over the coming years.
The market for antibodies in the Asia Pacific region is anticipated to evolve at the fastest CAGR of all regions owing to increasing awareness of chronic diseases and rising spending on healthcare infrastructure development. Low regulatory restrictions in this region make it an attractive choice for antibody companies and drive market potential at an exceptional pace.
China and India are projected to be key markets in this region as governments in these countries are increasing their spending on healthcare infrastructure development.
The Europe antibodies market is also predicted to account for a significant market share owing to the rising incidence of cancers, cardiovascular disorders, autoimmune diseases, and high spending on antibody R&D. France, Germany, and Italy are expected to lead market growth in this region throughout the forecast period. The market in this region is projected to exhibit evolution at a CAGR of 11.2% through 2032.
Report Attributes |
Details |
|---|---|
|
Antibodies Market Size (2022) |
US$ 197.3 Billion |
|
Projected Market Value (2032F) |
US$ 608.5 Billion |
|
Global Market Growth Rate (2022-2032) |
11.9% CAGR |
|
North America Market Share (2032F) |
49% |
|
China Market Share (2022) |
10% |
|
Europe Market Growth Rate (2022-2032) |
11.2% |
|
Key Companies |
|
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Demand Analysis of Antibodies (2017-2021) in Comparison to Market Forecasts (2022-2032)
Focus on healthcare has bolstered in recent years and this trend has led to a substantial increase in healthcare research and development activity across the world. Antibodies play a vital role in combating diseases and treating them, which is what primarily drives the demand for antibodies.
The patent expiry of many antibodies is also expected to provide new opportunities for producers of antibodies as they focus on the development of new biosimilar monoclonal antibodies to meet the supply gaps created from the patent expiry of renowned products.
However, risks associated with the use of antibodies and the high costs of their development are predicted to obstruct the antibodies market going forward. Sales of antibodies are anticipated to increase at an astronomical CAGR of 11.9% through 2032.
What is Shaping Antibody Drug Market Growth Potential?
“Increasing Research in Healthcare Industry Boosts Demand for Antibody Production”
The world has witnessed a notable increase in the prevalence of chronic diseases and frequent outbreaks of viral ailments have led to an increased focus on healthcare. This increased focus on healthcare has pushed governments to increase their spending on research and development of novel treatments, which is expected to favor antibodies market potential throughout the forecast period.
The high prevalence of rare diseases and increasing use of monoclonal antibodies and polyclonal antibodies in their treatment and diagnosis is also projected to uplift antibody demand over the years to come. The growing popularity of personalized medicine is anticipated to drive demand for research for custom antibodies through 2032.
Startup Ecosystem: How Opportune is the Antibodies Market for New Companies?
“Start-ups Should Focus on Expansion of Their Research Scope to Advance Innovation”
Upcoming market players are expected to focus on expanding their research and business scope by the acquisition of new funding through financing rounds. New companies are exploring the use of advanced technologies to simplify the process of development of new monoclonal antibody therapeutics, nanobodies, and other types of therapeutic antibodies.
- In September 2022, Great Bay Bio (GBB), a Hong Kong-based start-up, announced the completion of its Pre-series B funding round at US$ 15 million. The company is expected to use the funding to accelerate the development of artificial intelligence (AI) powered bioprocessing platforms to improve the CMC process of various biological drugs such as monoclonal antibodies, fusion proteins, etc.
- In September 2022, Capstan Therapeutics, a start-up focused on developing therapeutics for diseases with unmet clinical needs, announced its launch with US$ 165 million for in-vivo cell engineering. The company is developing in-vivo CAR therapies, which enable cell engineering while they remain in the body.
Renowned market players are launching new partnerships and initiatives that could help new companies to make a mark in the highly competitive antibodies marketplace.
- In July 2022, Versant Ventures, a renowned backer of biotechnology companies revealed a new partnership with AbCellera, an antibody discovery-focused company. Through this partnership, Versant will provide start-ups with antibodies matched with their target disease from AbCellera and fast-track the research and development process by a substantial margin.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
Why are Suppliers of Antibodies Investing in the U.S.?
“Supportive Government Initiatives & High Spending on Healthcare R&D”
The United States is known for its developed healthcare infrastructure and extensive research activity, which makes it a favorable market for antibodies. The presence of modern healthcare infrastructure and the presence of leading market players also make the U.S. a highly rewarding market for antibody suppliers and manufacturers. Increasing support from the government of the U.S. is another factor that will uplift antibodies market over the coming years.
High prevalence of chronic diseases, growing aging population, high patient spending potential, and increasing incidence of cancers are other factors that positively impact the antibodies market through 2032 in the country. Cancer monoclonal antibodies are anticipated to witness high demand in the United States across the forecast period.
How Will the China Antibodies Market Evolve?
“Rising Awareness of Chronic Diseases & Growing Senescent Population”
Focus on healthcare in China is increasing and this trend was particularly boosted by the outbreak of coronavirus in 2020, which is expected to primarily drive antibodies market in the country through 2032. Awareness of chronic diseases, the growing geriatric population, increasing healthcare expenditure, and favorable government policies to boost healthcare infrastructure development are other factors that positively impact antibodies market growth in China.
- A “Chinese Antibody Society” was also established and started by the government of China to ensure speedy approval of China-made antibody-based drugs and therapeutics across the world and provide effective marketing solutions for the same.
The China antibodies market at present accounts for 10% of the global market share.
Category-wise Insights
Which End User Accounts for Highest Demand for Antibodies?
“Biopharmaceutical Companies Set to Lead Global Antibody Demand”
The global antibodies market, based on end user, is segmented into biopharmaceutical companies, contract research organizations (CROs), academic & research institutes, forensic science laboratories, food & beverage companies, diagnostic centers, and others.
Increasing demand for new drugs and pharmaceuticals owing to the high prevalence of chronic diseases across the world is projected to drive demand for antibodies in biopharmaceutical companies across the forecast period. Increasing investments in drug development and manufacturing are projected to favor antibody demand in pharmaceutical companies and account for a dominant market share in the antibodies marketplace.
Competitive Landscape
Top companies in the antibodies market are focusing on advancing their research and fast-tracking the development of new antibodies to launch new products and gain a competitive advantage over other market players.
- On September 19, 2022, Sandoz, a leader in biosimilars and generic pharmaceuticals, announced the progress of its biosimilar pipeline. This included positive results for the proposed biosimilar denosumab from ROSALIA Phase I/III clinical trial study. Denosumab is a human monoclonal antibody designed to bind and inhibit RANKL to reduce bone loss.
Leading suppliers of antibodies are also eyeing partnerships, collaborations, and mergers to increase their market presence and widen their research scope.
- In March 2022, Sanofi, a leading pharmaceutical organization announced that it will partner with IGM Biosciences to create, develop, manufacture, and commercialize six new immunoglobulin M antibody agonists. Through this partnership, Sanofi has committed to over US$ 6 billion in potential milestone payments.
Key Segments in Antibodies Industry Research
-
By Product Type :
- Monoclonal Antibodies
- Polyclonal Antibodies
- Immune Checkpoint Antibodies
- Epitope Tag Antibodies
- Isotype Control Antibodies
- Primary Antibodies
- Assay Antibodies
- Others
-
By Application :
- Drug Discovery & Development
- Basic Research
- Toxicity Screening
- Biopharmaceutical Production
- Drug Screening
- Tissue Engineering
- Forensic Testing
- Others
-
By End User :
- Biopharmaceutical Companies
- Contract Research Organizations (CROs)
- Academic & Research Institutes
- Forensic Science Laboratories
- Food & Beverage Companies
- Diagnostic Centers
- Others
-
By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
Table of Content
1. Global Antibodies Market - Executive Summary 1.1. Global Market Overview 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Fact.MR Analysis and Recommendations 2. Global Antibodies Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Introduction and Definition 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on Antibodies 3.1.2. COVID-19 Crisis and Impact on Aprotic Solvent Prices 3.1.3. COVID-19 Impact Benchmark with Previous Crisis 3.1.3.1. Change in Antibodies Demand 3.1.3.2. Before and After COVID-19 Crisis (Projected) 3.1.3.3. Before and After Sub-prime Crisis – 2008 (Actual) 3.1.3.4. Change in Demand post Recovery Period (After Each Crisis) 3.1.4. Impact on Market and Value (US$ Mn) 3.1.4.1. Likely Loss of Value in 2020 3.1.4.2. Mid-term and Long Term Forecast 3.1.4.3. Quarter by Quarter Demand and Recovery Assessment 3.1.5. Anticipated Demand and Value Recovery Curve 3.1.5.1. Likelihood of U-Shape Recovery 3.1.5.2. Likelihood of L-Shape Recovery 3.1.6. Recovery Period Assessment by Key Countries 3.1.7. Recovery Assessment by Key Market Segments 3.1.8. Action Points and Recommendations for Suppliers 3.1.9. Impact on Trade Balance 3.2. Key Trends Impacting the Market 3.3. Formulation and Application Development Trends 4. Market Background and foundation Data Points 4.1. Need of the Hour for Industries 4.2. Industry Wise Industry 4.0 4.3. Antibodies – Strategic Priorities 4.4. Life Cycle Stage 4.5. Importance of Technology 4.6. Use Cases of Antibodies 4.7. Forecast Factors: Relevance and Impact 4.8. Investment Feasibility Matrix 4.9. PESTLE Analysis 4.10. Porter’s Five Forces Analysis 4.11. Market Dynamics 4.11.1. Drivers 4.11.2. Restraints 4.11.3. Opportunity Analysis 4.11.4. Trend 5. Global Antibodies Market Demand (US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032 5.1. Historical Market Value (US$ Mn) Analysis, 2017-2021 5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032 5.2.1. Y-o-Y Growth Trend Analysis 5.2.2. Absolute $ Opportunity Analysis 6. Global Antibodies Market Analysis 2017-2021 and Forecast 2022-2032, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Value (US$ Mn) Analysis By Application, 2017-2021 6.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Application, 2022-2032 6.3.1. Drug Discovery & Development 6.3.2. Basic Research 6.3.3. Toxicity Screening 6.3.4. Biopharmaceutical Production 6.3.5. Drug Screening 6.3.6. Tissue Engineering 6.3.7. Forensic Testing 6.3.8. Others 6.4. Market Attractiveness Analysis By Application 7. Global Antibodies Market Analysis 2017-2021 and Forecast 2022-2032, by Product Type 7.1. Introduction / Key Findings 7.2. Historical Market Value (US$ Mn) Analysis By Product Type , 2017-2021 7.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Product Type, 2022-2032 7.3.1. Monoclonal Antibodies 7.3.2. Polyclonal Antibodies 7.3.3. Immune Checkpoint Antibodies 7.3.4. Epitope Tag Antibodies 7.3.5. Isotype Control Antibodies 7.3.6. Primary Antibodies 7.3.7. Assay Antibodies 7.3.8. Others 7.4. Market Attractiveness Analysis By Product Type 8. Global Antibodies Market Analysis 2017-2021 and Forecast 2022-2032, by End User 8.1. Introduction / Key Findings 8.2. Historical Market Value (US$ Mn) Analysis By End User, 2017-2021 8.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By End User, 2022-2032 8.3.1. Biopharmaceutical Companies 8.3.2. Contract Research Organizations (CROs) 8.3.3. Academic & Research Institutes 8.3.4. Forensic Science Laboratories 8.3.5. Food & Beverage Companies 8.3.6. Diagnostic Centers 8.3.7. Others 8.4. Market Attractiveness Analysis By End User 9. Global Antibodies Market Analysis 2017-2021 and Forecast 2022-2032, by Region 9.1. Introduction / Key Findings 9.2. Historical Market Value (US$ Mn) Analysis By Region, 2017-2021 9.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. East Asia 9.3.5. South Asia & Oceania 9.3.6. Middle East and Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Antibodies Market Analysis 2017-2021 and Forecast 2022-2032 10.1. Introduction / Key Findings 10.2. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.3. Market Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.3.1. By Country 10.3.1.1. U.S. 10.3.1.2. Canada 10.3.2. By Application 10.3.3. By Product Type 10.4. Market Attractiveness Analysis 10.4.1. By Country 10.4.2. By Application 10.4.3. By Product Type 11. Latin America Antibodies Market Analysis 2017-2021 and Forecast 2022-2032 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 11.3.1. By Country 11.3.1.1. Brazil 11.3.1.2. Mexico 11.3.1.3. Rest of Latin America 11.3.2. By Application 11.3.3. By Product Type 11.3.4. By End User 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Application 11.4.3. By Product Type 11.4.4. By End User 12. Europe Antibodies Market Analysis 2017-2021 and Forecast 2022-2032 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 12.3.1. By Country 12.3.1.1. Germany 12.3.1.2. France 12.3.1.3. Italy 12.3.1.4. Spain 12.3.1.5. UK 12.3.1.6. BENELUX 12.3.1.7. Russia 12.3.1.8. Rest of Europe 12.3.2. By Application 12.3.3. By Product Type 12.3.4. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Application 12.4.3. By Product Type 12.4.4. By End User 13. East Asia Antibodies Market Analysis 2017-2021 and Forecast 2022-2032 13.1. Introduction / Key Findings 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 13.3.1. By Country 13.3.1.1. China 13.3.1.2. Japan 13.3.1.3. South Korea 13.3.2. By Application 13.3.3. By Product Type 13.3.4. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Application 13.4.3. By Product Type 13.4.4. By End User 14. South Asia & Oceania Antibodies Market Analysis 2017-2021 and Forecast 2022-2032 14.1. Introduction / Key Findings 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Thailand 14.3.1.3. Malaysia 14.3.1.4. Singapore 14.3.1.5. Vietnam 14.3.1.6. ANZ 14.3.1.7. Rest of South Asia & Oceania 14.3.2. By Application 14.3.3. By Product Type 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Application 14.4.3. By Product Type 14.4.4. By End User 15. Middle East and Africa Antibodies Market Analysis 2017-2021 and Forecast 2022-2032 15.1. Introduction / Key Findings 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 15.3.1. By Country 15.3.1.1. GCC Countries 15.3.1.2. South Africa 15.3.1.3. Israel 15.3.1.4. Rest of Middle East and Africa (MEA) 15.3.2. By Application 15.3.3. By Product Type 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Application 15.4.3. By Product Type 15.4.4. By End User 16. Market Structure Analysis 16.1. Market Analysis by Tier of Companies 16.2. Market Concentration 16.3. Market Share Analysis of Top Players 16.4. Market Presence Analysis 17. Competition Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Competition Deep Dive 17.3.1. Novartis AG 17.3.1.1. Company Overview 17.3.1.2. Application overview 17.3.1.3. SWOT Analysis 17.3.1.4. Key Developments 17.3.2. F. Hoffmann-La Roche AG 17.3.2.1. Company Overview 17.3.2.2. Application overview 17.3.2.3. SWOT Analysis 17.3.2.4. Key Developments 17.3.3. Johnson & Johnson 17.3.3.1. Company Overview 17.3.3.2. Application overview 17.3.3.3. SWOT Analysis 17.3.3.4. Key Developments 17.3.4. Takeda Pharmaceutical Company Limited 17.3.4.1. Company Overview 17.3.4.2. Application overview 17.3.4.3. SWOT Analysis 17.3.4.4. Key Developments 17.3.5. Amgen Inc. 17.3.5.1. Company Overview 17.3.5.2. Application overview 17.3.5.3. SWOT Analysis 17.3.5.4. Key Developments 17.3.6. Biogen Inc. 17.3.6.1. Company Overview 17.3.6.2. Application overview 17.3.6.3. SWOT Analysis 17.3.6.4. Key Developments 17.3.7. Bristol-Myers Squibb Company 17.3.7.1. Company Overview 17.3.7.2. Application overview 17.3.7.3. SWOT Analysis 17.3.7.4. Key Developments 17.3.8. AbbVie Inc. 17.3.8.1. Company Overview 17.3.8.2. Application overview 17.3.8.3. SWOT Analysis 17.3.8.4. Key Developments 17.3.9. Sanofi SA 17.3.9.1. Company Overview 17.3.9.2. Application overview 17.3.9.3. SWOT Analysis 17.3.9.4. Key Developments 17.3.10. Eli Lilly and Co. 17.3.10.1. Company Overview 17.3.10.2. Application overview 17.3.10.3. SWOT Analysis 17.3.10.4. Key Developments 18. Assumptions And Acronyms Used 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Antibodies Market Value (US$ Mn) Analysis, by Application, 2017-2021
Table 02: Global Antibodies Market Value (US$ Mn) Analysis, by Application, 2022-2032
Table 03: Global Antibodies Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2032
Table 04: Global Antibodies Market Value (US$ Mn) Analysis, by Product Type, 2017-2021
Table 05: Global Antibodies Market Value (US$ Mn) Analysis, by Product Type, 2022-2032
Table 06: Global Antibodies Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2022-2032
Table 07: Global Antibodies Market Value (US$ Mn) Analysis, by End User, 2017-2021
Table 08: Global Antibodies Market Value (US$ Mn) Analysis, by End User, 2022-2032
Table 09: Global Antibodies Market Value (US$ Mn) Opportunity Analysis, by End User, 2022-2032
Table 10: Global Antibodies Market Value (US$ Mn) Analysis, by Region, 2017-2021
Table 11: Global Antibodies Market Value (US$ Mn) Analysis, by Region, 2022-2032
Table 12: Global Antibodies Market Value (US$ Mn) Opportunity Analysis, by Region, 2022-2032
Table 13: North America Antibodies Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 14: North America Antibodies Market Value (US$ Mn) Analysis, by Country, 2022-2032
Table 15: North America Antibodies Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032
Table 16: North America Antibodies Market Value (US$ Mn) Analysis, by Application, 2017-2021
Table 17: North America Antibodies Market Value (US$ Mn) Analysis, by Application, 2022-2032
Table 18: North America Antibodies Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2032
Table 19: North America Antibodies Market Value (US$ Mn) Analysis, by Product Type, 2017-2021
Table 20: North America Antibodies Market Value (US$ Mn) Analysis, by Product Type, 2022-2032
Table 21: North America Antibodies Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2022-2032
Table 22: North America Antibodies Market Value (US$ Mn) Analysis, by End User, 2017-2021
Table 23: North America Antibodies Market Value (US$ Mn) Analysis, by End User, 2022-2032
Table 24: North America Antibodies Market Value (US$ Mn) Opportunity Analysis, by End User, 2022-2032
Table 25: Latin America Antibodies Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 26: Latin America Antibodies Market Value (US$ Mn) Analysis, by Country, 2022-2032
Table 27: Latin America Antibodies Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032
Table 28: Latin America Antibodies Market Value (US$ Mn) Analysis, by Application, 2017-2021
Table 29: Latin America Antibodies Market Value (US$ Mn) Analysis, by Application, 2022-2032
Table 30: Latin America Antibodies Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2032
Table 31: Latin America Antibodies Market Value (US$ Mn) Analysis, by Product Type, 2017-2021
Table 32: Latin America Antibodies Market Value (US$ Mn) Analysis, by Product Type, 2022-2032
Table 33: Latin America Antibodies Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2022-2032
Table 34: Latin America Antibodies Market Value (US$ Mn) Analysis, by End User, 2017-2021
Table 35: Latin America Antibodies Market Value (US$ Mn) Analysis, by End User, 2022-2032
Table 36: Latin America Antibodies Market Value (US$ Mn) Opportunity Analysis, by End User, 2022-2032
Table 37: Europe Antibodies Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 38: Europe Antibodies Market Value (US$ Mn) Analysis, by Country, 2022-2032
Table 39: Europe Antibodies Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032
Table 40: Europe Antibodies Market Value (US$ Mn) Analysis, by Application, 2017-2021
Table 41: Europe Antibodies Market Value (US$ Mn) Analysis, by Application, 2022-2032
Table 42: Europe Antibodies Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2032
Table 43: Europe Antibodies Market Value (US$ Mn) Analysis, by Product Type, 2017-2021
Table 44: Europe Antibodies Market Value (US$ Mn) Analysis, by Product Type, 2022-2032
Table 45: Europe Antibodies Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2022-2032
Table 46: Europe Antibodies Market Value (US$ Mn) Analysis, by End User, 2017-2021
Table 47: Europe Antibodies Market Value (US$ Mn) Analysis, by End User, 2022-2032
Table 48: Europe Antibodies Market Value (US$ Mn) Opportunity Analysis, by End User, 2022-2032
Table 49: East Asia Antibodies Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 50: East Asia Antibodies Market Value (US$ Mn) Analysis, by Country, 2022-2032
Table 51: East Asia Antibodies Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032
Table 52: East Asia Antibodies Market Value (US$ Mn) Analysis, by Application, 2017-2021
Table 53: East Asia Antibodies Market Value (US$ Mn) Analysis, by Application, 2022-2032
Table 54: East Asia Antibodies Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2032
Table 55: East Asia Antibodies Market Value (US$ Mn) Analysis, by Product Type, 2017-2021
Table 56: East Asia Antibodies Market Value (US$ Mn) Analysis, by Product Type, 2022-2032
Table 57: East Asia Antibodies Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2022-2032
Table 58: East Asia Antibodies Market Value (US$ Mn) Analysis, by End User, 2017-2021
Table 59: East Asia Antibodies Market Value (US$ Mn) Analysis, by End User, 2022-2032
Table 60: East Asia Antibodies Market Value (US$ Mn) Opportunity Analysis, by End User, 2022-2032
Table 61: South Asia & Oceania Antibodies Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 62: South Asia & Oceania Antibodies Market Value (US$ Mn) Analysis, by Country, 2022-2032
Table 63: South Asia & Oceania Antibodies Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032
Table 64: South Asia & Oceania Antibodies Market Value (US$ Mn) Analysis, by Application, 2017-2021
Table 65: South Asia & Oceania Antibodies Market Value (US$ Mn) Analysis, by Application, 2022-2032
Table 66: South Asia & Oceania Antibodies Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2032
Table 67: South Asia & Oceania Antibodies Market Value (US$ Mn) Analysis, by Product Type, 2017-2021
Table 68: South Asia & Oceania Antibodies Market Value (US$ Mn) Analysis, by Product Type, 2022-2032
Table 69: South Asia & Oceania Antibodies Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2022-2032
Table 70: South Asia & Oceania Antibodies Market Value (US$ Mn) Analysis, by End User, 2017-2021
Table 71: South Asia & Oceania Antibodies Market Value (US$ Mn) Analysis, by End User, 2022-2032
Table 72: South Asia & Oceania Antibodies Market Value (US$ Mn) Opportunity Analysis, by End User, 2022-2032
Table 73: MEA Antibodies Market Value (US$ Mn) Analysis, by Country, 2017-2021
Table 74: MEA Antibodies Market Value (US$ Mn) Analysis, by Country, 2022-2032
Table 75: MEA Antibodies Market Value (US$ Mn) Opportunity Analysis, by Country, 2022-2032
Table 76: MEA Antibodies Market Value (US$ Mn) Analysis, by Application, 2017-2021
Table 77: MEA Antibodies Market Value (US$ Mn) Analysis, by Application, 2022-2032
Table 78: MEA Antibodies Market Value (US$ Mn) Opportunity Analysis, by Application, 2022-2032
Table 79: MEA Antibodies Market Value (US$ Mn) Analysis, by Product Type, 2017-2021
Table 80: MEA Antibodies Market Value (US$ Mn) Analysis, by Product Type, 2022-2032
Table 81: MEA Antibodies Market Value (US$ Mn) Opportunity Analysis, by Product Type, 2022-2032
Table 82: MEA Antibodies Market Value (US$ Mn) Analysis, by End User, 2017-2021
Table 83: MEA Antibodies Market Value (US$ Mn) Analysis, by End User, 2022-2032
Table 84: MEA Antibodies Market Value (US$ Mn) Opportunity Analysis, by End User, 2022-2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Antibodies Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 02: Global Antibodies Market Value (US$ Mn) Forecast and Analysis, 2022-2032
Figure 03: Global Antibodies Market Value Y-o-Y Growth and Forecast, 2017-2032
Figure 04: Global Antibodies Market Incremental $ Opportunity, 2022-2032
Figure 05: Global Antibodies Market Share and BPS Analysis by Application, 2022 & 2032
Figure 06: Global Antibodies Market Y-o-Y Growth Projections by Application, 2022-2032
Figure 07: Global Antibodies Market Attractiveness Analysis by Application, 2022-2032
Figure 08: Global Antibodies Market Share and BPS Analysis by Product Type, 2022 & 2032
Figure 09: Global Antibodies Market Y-o-Y Growth Projections by Product Type, 2022-2032
Figure 10: Global Antibodies Market Attractiveness Analysis by Product Type, 2022-2032
Figure 11: Global Antibodies Market Share and BPS Analysis by End User, 2022 & 2032
Figure 12: Global Antibodies Market Y-o-Y Growth Projections by End User, 2022-2032
Figure 13: Global Antibodies Market Attractiveness Analysis by End User, 2022-2032
Figure 14: Global Antibodies Market Share and BPS Analysis by Region, 2022 & 2032
Figure 15: Global Antibodies Market Y-o-Y Growth Projections by Region, 2022-2032
Figure 16: Global Antibodies Market Attractiveness Analysis by Region, 2022-2032
Figure 17: North America Antibodies Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 18: North America Antibodies Market Value (US$ Mn) Forecast and Analysis, 2022-2032
Figure 19: North America Antibodies Market Value Y-o-Y Growth and Forecast, 2032
Figure 20: North America Antibodies Market Incremental $ Opportunity, 2022-2032
Figure 21: North America Antibodies Market Share Analysis by Country, 2022 & 2032
Figure 22: North America Antibodies Market Y-o-Y Growth Projection by Country, 2022-2032
Figure 23: North America Antibodies Market Attractiveness Analysis by Country, 2022-2032
Figure 24: North America Antibodies Market Share and BPS Analysis by Application, 2022 & 2032
Figure 25: North America Antibodies Market Y-o-Y Growth Projections by Application, 2022-2032
Figure 26: North America Antibodies Market Attractiveness Analysis by Application, 2022-2032
Figure 27: North America Antibodies Market Share and BPS Analysis by Product Type, 2022 & 2032
Figure 28: North America Antibodies Market Y-o-Y Growth Projections by Product Type, 2022-2032
Figure 29: North America Antibodies Market Attractiveness Analysis by Product Type, 2022-2032
Figure 30: North America Antibodies Market Share and BPS Analysis by End User, 2022 & 2032
Figure 31: North America Antibodies Market Y-o-Y Growth Projections by End User, 2022-2032
Figure 32: North America Antibodies Market Attractiveness Analysis by End User, 2022-2032
Figure 33: Latin America Antibodies Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 34: Latin America Antibodies Market Value (US$ Mn) Forecast and Analysis, 2022-2032
Figure 35: Latin America Antibodies Market Value Y-o-Y Growth and Forecast, 2017-2032
Figure 36: Latin America Antibodies Market Incremental $ Opportunity, 2022-2032
Figure 37: Latin America Antibodies Market Share Analysis by Country, 2022 & 2032
Figure 38: Latin America Antibodies Market Y-o-Y Growth Projection by Country, 2022-2032
Figure 39: Latin America Antibodies Market Attractiveness Analysis by Country, 2022-2032
Figure 40: Latin America Antibodies Market Share and BPS Analysis by Application, 2022 & 2032
Figure 41: Latin America Antibodies Market Y-o-Y Growth Projections by Application, 2022-2032
Figure 42: Latin America Antibodies Market Attractiveness Analysis by Application, 2022-2032
Figure 43: Latin America Antibodies Market Share and BPS Analysis by Product Type, 2022 & 2032
Figure 44: Latin America Antibodies Market Y-o-Y Growth Projections by Product Type, 2022-2032
Figure 45: Latin America Antibodies Market Attractiveness Analysis by Product Type, 2022-2032
Figure 46: Latin America Antibodies Market Share and BPS Analysis by End User, 2022 & 2032
Figure 47: Latin America Antibodies Market Y-o-Y Growth Projections by End User, 2022-2032
Figure 48: Latin America Antibodies Market Attractiveness Analysis by End User, 2022-2032
Figure 49: Europe Antibodies Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 50: Europe Antibodies Market Value (US$ Mn) Forecast and Analysis, 2022-2032
Figure 51: Europe Antibodies Market Value Y-o-Y Growth and Forecast, 2017-2032
Figure 52: Europe Antibodies Market Incremental $ Opportunity, 2022-2032
Figure 53: Europe Antibodies Market Share Analysis by Country, 2022 & 2032
Figure 54: Europe Antibodies Market Y-o-Y Growth Projection by Country, 2022-2032
Figure 55: Europe Antibodies Market Attractiveness Analysis by Country, 2022-2032
Figure 56: Europe Antibodies Market Share and BPS Analysis by Application, 2022 & 2032
Figure 57: Europe Antibodies Market Y-o-Y Growth Projections by Application, 2022-2032
Figure 58: Europe Antibodies Market Attractiveness Analysis by Application, 2022-2032
Figure 59: Europe Antibodies Market Share and BPS Analysis by Product Type, 2022 & 2032
Figure 60: Europe Antibodies Market Y-o-Y Growth Projections by Product Type, 2022-2032
Figure 61: Europe Antibodies Market Attractiveness Analysis by Product Type, 2022-2032
Figure 62: Europe Antibodies Market Share and BPS Analysis by End User, 2022 & 2032
Figure 63: Europe Antibodies Market Y-o-Y Growth Projections by End User, 2022-2032
Figure 64: Europe Antibodies Market Attractiveness Analysis by End User, 2022-2032
Figure 65: East Asia Antibodies Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 66: East Asia Antibodies Market Value (US$ Mn) Forecast and Analysis, 2022-2032
Figure 67: East Asia Antibodies Market Value Y-o-Y Growth and Forecast, 2017-2032
Figure 68: East Asia Antibodies Market Incremental $ Opportunity, 2022-2032
Figure 69: East Asia Antibodies Market Share Analysis by Country, 2022 & 2032
Figure 70: East Asia Antibodies Market Y-o-Y Growth Projection by Country, 2022-2032
Figure 71: East Asia Antibodies Market Attractiveness Analysis by Country, 2022-2032
Figure 72: East Asia Antibodies Market Share and BPS Analysis by Application, 2022 & 2032
Figure 73: East Asia Antibodies Market Y-o-Y Growth Projections by Application, 2022-2032
Figure 74: East Asia Antibodies Market Attractiveness Analysis by Application, 2022-2032
Figure 75: East Asia Antibodies Market Share and BPS Analysis by Product Type, 2022 & 2032
Figure 76: East Asia Antibodies Market Y-o-Y Growth Projections by Product Type, 2022-2032
Figure 77: East Asia Antibodies Market Attractiveness Analysis by Product Type, 2022-2032
Figure 78: East Asia Antibodies Market Share and BPS Analysis by End User, 2022 & 2032
Figure 79: East Asia Antibodies Market Y-o-Y Growth Projections by End User, 2022-2032
Figure 80: East Asia Antibodies Market Attractiveness Analysis by End User, 2022-2032
Figure 81: South Asia & Oceania Antibodies Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 82: South Asia & Oceania Antibodies Market Value (US$ Mn) Forecast and Analysis, 2022-2032
Figure 83: South Asia & Oceania Antibodies Market Value Y-o-Y Growth and Forecast, 2017-2032
Figure 84: South Asia & Oceania Antibodies Market Incremental $ Opportunity, 2022-2032
Figure 85: South Asia & Oceania Antibodies Market Share Analysis by Country, 2022 & 2032
Figure 86: South Asia & Oceania Antibodies Market Y-o-Y Growth Projection by Country, 2022-2032
Figure 87: South Asia & Oceania Antibodies Market Attractiveness Analysis by Country, 2022-2032
Figure 88: South Asia & Oceania Antibodies Market Share and BPS Analysis by Application, 2022 & 2032
Figure 89: South Asia & Oceania Antibodies Market Y-o-Y Growth Projections by Application, 2022-2032
Figure 90: South Asia & Oceania Antibodies Market Attractiveness Analysis by Application, 2022-2032
Figure 91: South Asia & Oceania Antibodies Market Share and BPS Analysis by Product Type, 2022 & 2032
Figure 92: South Asia & Oceania Antibodies Market Y-o-Y Growth Projections by Product Type, 2022-2032
Figure 93: South Asia & Oceania Antibodies Market Attractiveness Analysis by Product Type, 2022-2032
Figure 94: South Asia & Oceania Antibodies Market Share and BPS Analysis by End User, 2022 & 2032
Figure 95: South Asia & Oceania Antibodies Market Y-o-Y Growth Projections by End User, 2022-2032
Figure 96: South Asia & Oceania Antibodies Market Attractiveness Analysis by End User, 2022-2032
Figure 97: MEA Antibodies Market Value (US$ Mn) Historical Analysis, 2017-2021
Figure 98: MEA Antibodies Market Value (US$ Mn) Forecast and Analysis, 2022-2032
Figure 99: MEA Antibodies Market Value Y-o-Y Growth and Forecast, 2017-2032
Figure 100: MEA Antibodies Market Incremental $ Opportunity, 2022-2032
Figure 101: MEA Antibodies Market Share Analysis by Country, 2022 & 2032
Figure 102: MEA Antibodies Market Y-o-Y Growth Projection by Country, 2022-2032
Figure 103: MEA Antibodies Market Attractiveness Analysis by Country, 2022-2032
Figure 104: MEA Antibodies Market Share and BPS Analysis by Application, 2022 & 2032
Figure 105: MEA Antibodies Market Y-o-Y Growth Projections by Application, 2022-2032
Figure 106: MEA Antibodies Market Attractiveness Analysis by Application, 2022-2032
Figure 107: MEA Antibodies Market Share and BPS Analysis by Product Type, 2022 & 2032
Figure 108: MEA Antibodies Market Y-o-Y Growth Projections by Product Type, 2022-2032
Figure 109: MEA Antibodies Market Attractiveness Analysis by Product Type, 2022-2032
Figure 110: MEA Antibodies Market Share and BPS Analysis by End User, 2022 & 2032
Figure 111: MEA Antibodies Market Y-o-Y Growth Projections by End User, 2022-2032
Figure 112: MEA Antibodies Market Attractiveness Analysis by End User, 2022-2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the global antibodies market?
The global antibodies market accounts for a revenue of US$ 197.3 billion in 2022.
What is the expected antibodies market size for 2032?
The global market for antibodies is expected to reach US$ 608.5 billion by 2032.
What is the antibodies market predicted growth rate?
Demand for antibodies from 2022 to 2032 is projected to expand at a stellar CAGR of 11.9%.
What is the predicted market share for North America?
By 2032, the North American antibodies market is expected to hold a share of 49% in the global landscape.
Which prominent suppliers of antibodies are operating in the global marketplace?
Key suppliers of antibodies are Takeda Pharmaceutical Company Limited, Amgen Inc., Biogen Inc., Bristol-Myers Squibb Company, AbbVie Inc., Sanofi SA, and Eli Lilly and Co.
What statistics are revealed for China in this Fact.MR research?
The China antibodies market accounts for 10% of the global market share.
Antibodies Market